Inventor · disambiguated record
Anthony Ingall
Also filed as: INGALL ANTHONY · INGALL ANTHONY H · INGALL ANTHONY HOWARD
18 granted patents·13 pending applications·495 citations·filing 1979–2014
95Inventor score
Files withASTRAZENECA AB13ASTRAZENECA UK LTD5ASTRA PHARMA PROD4ASTRAZENECA AB A SWEDEN CORP2FISONS PLC2
Top patents by PatentIndex Score
31 records- 0193US7250419B2Trisubstituted triazolopyrimidines for use in platelet aggregation inhibitionASTRAZENECA AB·Filed 2005·Granted Jul 31, 2007·16 cites·14 claims
- 0292US6525060B1Triazolo(4,5-d)pyrimidine compoundsASTRAZENECA UK LTD·Filed 1999·Granted Feb 25, 2003·59 cites·14 claims
- 0390US6251910B11,2,3-triazolo[4,5-d]pyrimidines as P2T receptor antagonistsASTRAZENECA UK LTD·Filed 1998·Granted Jun 26, 2001·55 cites·14 claims
- 0490US5721219AN-alkyl-2-substituted ATP analogues and administration to inhibit platelet aggregationASTRA PHARMA PROD·Filed 1995·Granted Feb 24, 1998·85 cites·12 claims
- 0589US6974868B2CompoundsASTRAZENECA AB·Filed 2002·Granted Dec 13, 2005·20 cites·2 claims
- 0686US5747496AInhibitors of platelet aggregationASTRA PHARMA PROD·Filed 1996·Granted May 5, 1998·72 cites·19 claims
- 0786US4851419ACertain 2-pyridinyl-phenylsulfinyl-benzoxazoles, the corresponding benzothiazoles or benzimidazoles having anti-inflammatory or gastric acid secretion inhibition activityFISONS PLC·Filed 1986·Granted Jul 25, 1989·24 cites·6 claims
- 0883US7064126B2CompoundsASTRAZENECA AB·Filed 2004·Granted Jun 20, 2006·17 cites·11 claims
- 0980US4900751A2-Pyridinyl-phenyl-sulphinyl-and-phenyl-thio-benzimidazoles having antiflammatory or gastic acid secretion inhibition activityFISONS PLC·Filed 1987·Granted Feb 13, 1990·32 cites·9 claims
- 1078US5955447AN-alkyl-2-substituted ATP analogues for treatment of embolic disease conditionsASTRA PHARMA PROD·Filed 1997·Granted Sep 21, 1999·44 cites·7 claims
- 1174US5654285AADP and ATP analogues, process for making and administration to inhibit ADP-induced platelet aggregationASTRA PHARMA PROD·Filed 1995·Granted Aug 5, 1997·38 cites·11 claims
- 1273US7384950B2Thienopyrimidinediones and their use in the modulation of autoimmune diseaseASTRAZENECA AB·Filed 2002·Granted Jun 10, 2008·7 cites·12 claims
- 1372US7393854B2Thienopyrimidinedinones and their use in modulation of autoimmune diseaseASTRAZENECA AB·Filed 2004·Granted Jul 1, 2008·5 cites·17 claims
- 1471US2010069408A1Trisubstituted triazolopyrimidines for use in platelet aggregation inhibitionASTRAZENECA AB·Filed 2009·Application pending·0 cites
- 1568US2008214812A1Trisubstituted triazolopyrimidines for use in platelet aggregation inhibitionASTRAZENECA AB·Filed 2008·Application pending·0 cites
- 1668US2015152111A1Trisubstituted triazolopyrimidines for use in platelet aggregation inhibitionASTRAZENECA UK LTD·Filed 2014·Application pending·0 cites
- 1766US7361660B2Chemical compoundsASTRAZENECA AB·Filed 2002·Granted Apr 22, 2008·4 cites·15 claims
- 1866US2014296258A1Trisubstituted triazolopyrimidines for use in platelet aggregation inhibitonASTRAZENECA UK LTD·Filed 2013·Application pending·0 cites
- 1964US2007265282A1Novel compoundsASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 2064US2013109702A1Trisubstituted triazolopyrimidines for use in platelet aggregation inhibitionASTRAZENECA AB·Filed 2012·Application pending·0 cites
- 2162US2013072503A1Trisubstituted triazolopyrimidines for use in platelet aggregation inhibitionHARDERN DAVID·Filed 2012·Application pending·0 cites
- 2261US6890923B2CompoundsASTRAZENECA AB·Filed 2002·Granted May 10, 2005·1 cites·11 claims
- 2361US2012165348A1Novel compoundsHARDERN DAVID·Filed 2011·Application pending·0 cites
- 2459US6297232B1Triazolo[4,5-D]pyrimidinyl derivatives and their use as medicamentsASTRAZENECA AB·Filed 1997·Granted Oct 2, 2001·15 cites·14 claims
- 2554US2008207642A1Thienopyrimidinediones and Their Use in the Modulation of Autoimmune DiseaseREYNOLDS RACHEL HEULWEN·Filed 2008·Application pending·0 cites
- 2651US2006223809A1Novel compoundsASTRAZENECA AB A SWEDEN CORP·Filed 2006·Application pending·0 cites
- 2751US2008153855A1Chemical CompoundsASTRAZENECA AB A SWEDEN CORP·Filed 2008·Application pending·0 cites
- 2844US2009221653A17-(2-amino-1-hydroxy-ethyl)-4-hydroxybenzothiazol-2(3H)-one-derivatives as beta2 adrenoreceptor agonistsASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 2936US4228173AThiopyrano-benzopyrans, compositions and method of use thereofFISONS LTD·Filed 1979·Granted Oct 14, 1980·1 cites·9 claims
- 3036US2004014634A1Thieno[2,3-d]pyrimidinediones and their use as pharmaceuticalsFiled 2001·Application pending·0 cites
- 3135USRE46276ETriazolo(4,5-D)pyrimidine compoundsASTRAZENECA UK LTD·Filed 1999·Granted Jan 17, 2017·0 cites·23 claims
Join the waitlist — get patent alerts
Get an alert when Anthony Ingall files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →